1.Employment among multiple sclerosis patients in Hong Kong
Kwok-Kwong Lau ; Alexander YL Lau ; Ellen LM Yu ; Kam-Mei Lau ; Alma Au ; Iris Chan ; Wing-Chi Fong ; Tak-Hon Tsoi ; Ping-Wing Ng ; Patrick CK Li
Neurology Asia 2016;21(2):161-167
Objective: Employment is important for patients with chronic illness, and to remain employed is a
robust support to them. This study aimed to examine the employment rate and to identify factors
associated with employment among multiple sclerosis (MS) in Hong Kong.
Methods: A cross-sectional study was performed from 2010 to 2011 at five major public hospitals.
Fifty-nine clinical definite MS patients with no evidence of dementia (Mini-Mental State Examination
≥ 22) were recruited. Demographic data and neuropsychological test results including memory, visual
perception, psychological well-being, motor, executive domain and processing speed were collected.
Principal component analysis and logistic regression with multiple imputation were used in data
analyses. Results: The employment rate among MS patients was 56%. Patients with better cognitive
functions were more likely to be employed (p=0.002). No significant association was found between
employment status and age, gender, level of education, types of MS, disease duration, frequency of
relapse or use of interferon.
Conclusion: MS patients had high unemployment rate (44%) which was 11.5 times higher than the
general population in Hong Kong. MS patients with better cognitive functions had higher employment
rates.
Multiple Sclerosis
3.Somali woman with multiple sclerosis, a case report
Joyce Pauline Joseph ; Suganthi Cinnasami ; Md Hanip Rafia
Neurology Asia 2017;22(1):81-84
There is variable prevalence of multiple sclerosis, higher in those residing in latitude away from
the equator, and among the Caucasian population. Multiple sclerosis has not been reported in some
countries, partly related to access to modern medicine. Although multiple sclerosis has been reported
among the Somali diaspora, it has not been reported among the residents in Somalia. We report an
adult Somali woman who has relapsing remitting multiple sclerosis for 8 years, affecting the optic
nerves, cerebellum and spinal cord.
Multiple Sclerosis
4.Reconstitution and Binding Analysis of a Human alphabeta TCR Restricted to the HLA - A2 / MAG Peptide Complex.
Korean Journal of Immunology 1997;19(2):197-208
No abstract available.
Humans*
;
Multiple Sclerosis
5.The role of psychological resilience, severity of disease and treatment adherence in the prediction of health-related quality of life in patients with multiple sclerosis
Habib Hadianfard ; Nahid Ashjazadeh ; Soodabe Feridoni ; Elham Farjam
Neurology Asia 2015;20(3):263-268
Objective: This cross-sectional study aims to evaluate the impact of the disability status, psychological
resilience, and treatment adherence on health-related quality of life (QOL) in patients with multiple
sclerosis (MS). Methods: One hundred MS outpatients, 80 women and 20 men, referred to a clinic
of Shiraz University of Medical Sciences, were eligible to participate. MS was diagnosed by 2010
revised Mc-Donald criteria. The QOL and resilience were evaluated by the Medical Outcomes Study
Short-Form (SF-36) and Connor-Davidson Resilience Scale (CD-RISC) respectively. Medication
adherence and severity of disease were assessed by the Morisky Medication Adherence Scale (MMAS)
and expanded disability status state (EDSS) scores respectively. Results: Stepwise multiple regressions
showed that in the first model, the disability status was the best predictor which accounted for 28.1%
of the variance in QOL. In the second model, both the disability status and resilience explained 50.6%
of the variation in QOL.
Conclusion: The findings showed that the severity of the disease is a strong predictor which has
adverse effects on the physical component of health-related QOL in the patients with MS. Both
psychological resilience and treatment adherence have positive influence on mental component of
QOL in these patients.
Multiple Sclerosis
;
Quality of Life
6.Cluster-tic syndrome and bilateral internuclear ophthalmoplegia as the manifestation of multiple sclerosis
Ali Ulvi Uca ; Hasan Hüseyin Kozak
Neurology Asia 2015;20(3):305-307
This report describes a 35-year-old female suffering from a cluster-tic syndrome and bilateral internuclear
ophthalmoplegia as the initial manifestation of multiple sclerosis. Magnetic resonance imaging of the
brain revealed multiple pontine hyperintense lesions. To our knowledge, there is no previous report
of multiple sclerosis presenting as cluster-tic syndrome and bilateral internuclear ophthalmoplegia in
the literature. The cluster headache attacks and peri-ocular neuralgiform pain resolved after treatment
with intravenous methyl-prednisolone and oral carbamazepine.
Multiple Sclerosis
;
Headache Disorders
7.Use of complementary and alternative medicine among people with multiple sclerosis in Eastern Turkey
Neurology Asia 2016;21(1):63-71
Objective:The purpose of this study was to examine the use of complementary and alternative medicine
(CAM) in patients with multiple sclerosis (MS) living in eastern Turkey as well as the factors affecting
the use of CAM modalities. Methods:This is a descriptive and cross-sectional study. Data were obtained
from 130 patients with MS at the neurology clinics of Ataturk University. Results: Out of all patients
surveyed, 61.5% reported use of at least one form of CAM. The most common three modalities used
by these patients were herbs taken orally, relaxation therapies and prayer, with rates of 55.5%, 26.3%
and 18.8%, respectively.Massage and relaxation therapies were perceived as very effective by more
than half of study participants.It was determined that variables such as education level, residential
area and duration of disease affected the use of CAM (P < .05).
Conclusions: CAM therapy is widely used by patients with MS in eastern Turkey.
Multiple Sclerosis
;
Complementary Therapies
8.Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: Is It the End?
Vascular Specialist International 2018;34(1):16-18
No abstract available.
Multiple Sclerosis
;
Venous Insufficiency
9.Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta.
Kyu Sik SHIN ; Jae Gun PARK ; Min Su PARK
Journal of the Korean Neurological Association 2016;34(1):77-79
No abstract available.
Humans
;
Interferon-beta*
;
Interferons*
;
Multiple Sclerosis
;
Multiple Sclerosis, Relapsing-Remitting*
10.Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta.
Kyu Sik SHIN ; Jae Gun PARK ; Min Su PARK
Journal of the Korean Neurological Association 2016;34(1):77-79
No abstract available.
Humans
;
Interferon-beta*
;
Interferons*
;
Multiple Sclerosis
;
Multiple Sclerosis, Relapsing-Remitting*